nafamostat has been researched along with Hypercholesterolemia in 2 studies
nafamostat: inhibitor of trypsin, plasmin, pancreatic kallikrein, plasma kallikrein & thrombin; strongly inhibits esterolytic activities of C1r & C1 esterase complement-mediated hemolysis; antineoplastic
Hypercholesterolemia: A condition with abnormally high levels of CHOLESTEROL in the blood. It is defined as a cholesterol value exceeding the 95th percentile for the population.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kojima, S | 2 |
| Shiba, M | 1 |
| Kuramochi, M | 2 |
| Yamamoto, A | 1 |
| Yoshitomi, Y | 1 |
| Sugi, T | 1 |
| Matsumoto, Y | 1 |
| Yano, M | 1 |
2 other studies available for nafamostat and Hypercholesterolemia
| Article | Year |
|---|---|
Effect of nafamostat mesilate on bradykinin generation and hemodynamics during LDL apheresis.
Topics: Adolescent; Adult; Benzamidines; Blood Component Removal; Bradykinin; Female; Guanidines; Hemodynami | 1995 |
Changes in plasma levels of cyclic nucleotides during low-density lipoprotein apheresis.
Topics: Adrenomedullin; Anticoagulants; Benzamidines; Blood Component Removal; Bradykinin; Cyclic AMP; Cycli | 1998 |